day 1 agenda
| World Congress on Vaccines July 10-11, 2025 @ Vienna, Austria |
||
| Day-1 (July 10, 2025) | ||
| 08:00-09:00 | Registrations | |
| 09:00-09:10 | Welcome Remarks by Moderator | |
| Keynote Talks | ||
| Liang Zhou, University of Florida, USA | 09:10-09:40 | The role of Innate Lymphoid Cells in Mucosal Infection |
| Nisha J Garg, Washington University, USA | 09:40-10:10 | Subunit nanovaccine elicited T cell functional activation controls Trypanosoma cruzi mediated maternal and placental tissue damage and improves pregnancy outcomes in mice |
| Monica Lahra, NSW Health Pathology, Australia | 10:10-10:40 | Multidrug resistant N. gonorrhoeae |
| Ying Liao, Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, China | 10:40-11:10 | Coronavirus Nucleocapsid Protein Enhances p-PKCα Binding to RACK1: Implications for Inhibition of Nucleocytoplasmic Trafficking and Suppression of the Innate Immune Response |
| Group Photo & Refreshment Break (11:10-11:30) | ||
| Technical Session-I | ||
| Session Chairs: TBA | ||
| Jooeun Bae, Harvard Medical School, USA | 11:30-11:50 | Combinational Immunotherapy with Multi-antigen targeting Cancer Vaccine |
| Júlia Vergara-Alert, Institute of Agrifood Research and Technology, Spain | 11:50-12:10 | Zoo-in-a-dish. How organoids are reshaping zoonotic disease research |
| Lina Souan, King Hussein Cancer Center, Jordan | 12:10-12:30 | Effectiveness and Duration of Anti-RBD SARS-CoV-2 IgG Response Across Vaccines: Implications for Vaccine Strategies |
| Shin, Yeun-Kyung, Animal and Plant Quarantine Agency, South Korea | 12:30-12:50 | Propagation of porcine reproductive and respiratory syndrome virus increases in PRRSV-susceptible porcine kidney cells modifying LGP2 and RIG-I |
| I Y Saleem, Liverpool John Moores University, UK | 12:50-13:10 | Inhalable Nanovaccine Targeting Pneumococcal Proteins for Lung Protection |
| Lunch Break @ Restaurant (13:10-14:10) | ||
| Technical Session-II | ||
| Session Chairs: TBA | ||
| Ximeng Han, Jenner Institute, University of Oxford, UK | 14:10-14:30 | Preclinical Development of an Enhanced-Immunogenicity Pfs230-Pfs25 Malaria Transmission-Blocking Vaccine |
| Baek Kim, Vernagen LLC, USA | 14:30-14:50 | Immunogenicity and protective efficacy of Respiratory Syncytial Virus mRNA vaccine encoding the F protein of both RSV subtypes A and B in a BALB/c mouse model |
| João Luis Garcia, Londrina State University, Spain | 14:50-15:10 | Vaccines against Toxoplasma gondii: the past, the present and the future |
| Yoon-Hee Lee, Animal and Plant Quarantine Agency, South Korea | 15:10-15:30 | The appication of Nano-Luciferase based biosensor for the detection of FMDV(Foot and Mouth Disease Virus) type Asia1 |
| Qunying Mao, National Institutes for Food and Drug Control, China | 15:30-15:50 | Establishment of the 1st Chinese national standard for CA6 neutralizing antibody |
| Refreshment Break (15:50-16:00) | ||
| Xiufen Zheng, Western University, Canada | 16:00-16:20 | Potentials and challenges of circular RNA as a therapy/vaccine in treating diseases |
| Maja Mockenhaupt, University of Freiburg, Germany | 16:20-16:40 | Infections as possible trigger of epidermal necrolysis |
| Ximeng Han, University of Oxford, United Kingdom | 16:40-17:00 | Preclinical Development of an Enhanced-Immunogenicity Pfs230-Pfs25 Malaria Transmission-Blocking Vaccine |
| Pannel Discussions | ||
day 2 agenda
| Day-2 (July 11, 2025) | ||
| Keynote Talks | ||
| Tian Wang,University of Texas Medical Branch, USA | 09:30-10:00 | Development of safe and efficacious vaccines against emerging arboviruses |
| Jerald Sadoff, Centivax Inc, USA | 10:00-10:30 | Universal vaccines against influenza and other pathogens |
| Taijiao Jiang, Guangzhou National Laboratory, China | 10:30-11:00 | Modeling influenza antigenic evolution for vaccination by PREDAC |
| 11:00-11:30 | Slot Available | |
| Refreshment Break (11:30-11:50) | ||
| Technical Session-III | ||
| Session Chairs: TBA | ||
| Jerina Jaho, University "Ismail Qemali" Vlore, Albania | 11:50-12:10 | Patients with HIV and Hepatitis B co-infection present special requirements for their management |
| Pooja Goel, The Lyndhurst Surgery, UK | 12:10-12:30 | Barriers to the Flu Vaccination: Patients’ Perspective within a London GP |
| Hamsa Taher Tayeb, King Faisal Specialist Hospital & Research Center, Saudi Arabia | 12:30-12:50 | Implementation of Next Generation Sequencing (NGS) as a Diagnostic Tool in Infectious Diseases |
| Lunch Break @ Restaurant (12:50-14:00) | ||
| Poster Presentations(14:00-14:30) | ||
| Technical Session-IV | ||
| Session Chairs: TBA | ||
| Ming-Chung Kan, Vaxsia Biomedical Inc, Taiwan | 14:30-14:50 | A self-adjuvanted protein nanoparticle that stimulates Ultra-High affinity antibodies |
| Polona Kogovšek, National institute of biology, Slovenia | 14:50-15:10 | Evaluation of the antiviral activity of compounds using computational, bioassay, molecular biology and electron microscopy techniques |
| Szu-Hao Kung, National Yang Ming Chiao Tung University, Taiwan | 15:10-15:30 | Development of ionophore antibiotics as antiviral agents against enteroviruses and coronaviruses |
| Filomena Fiorito, University of Naples Federico II, Italy | 15:30-15:50 | TBA |
| 15:50-16:10 | Slot Available | |
| Refreshment Break (16:10-16:30) | ||
| Luca Del Sorbo, University of Naples Federico II, Italy | 16:30-16:50 | TBA |
| 16:50-17:10 | Slot Available | |
| 17:10-17:30 | Slot Available | |
| Award Ceremony | ||
| Day 2 Concludes | ||
| NOTE: This is Tentative program and subject to change | ||
| For more information, Contact @ ryan_cooper@vaccine-congress.org | ||